Please enable JavaScript to continue using this application.

Compare $SPRB vs $TNYA | Chartloom

Compare

$SPRB vs $TNYA

Spruce Biosciences, Inc · Tenaya Therapeutics Inc

SPRB

Spruce Biosciences, Inc

TNYA

Tenaya Therapeutics Inc

Compare $SPRB vs $TNYA

Comparing Spruce Biosciences, Inc and Tenaya Therapeutics Inc

SPRBSpruce Biosciences, Inc

TNYATenaya Therapeutics Inc

SPRBSpruce Biosciences, Inc

Market cap

$121M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-51.4%

52W performance

-72.5%

FCF yield

-35.3%

TNYATenaya Therapeutics Inc

Market cap

$126M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

20.11x

Rev growth (TTM)

—

YTD performance

-21.0%

52W performance

-68.3%

FCF yield

-41.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SPRB

TNYA

Detailed metrics comparison

SPRB

Spruce Biosciences, Inc

TNYA

Tenaya Therapeutics Inc

Market Cap

SPRB$121M

TNYA$126M

Enterprise Value

SPRB$32M

TNYA$48M

Price

SPRB$44.05

TNYA$0.58

P/E Ratio

SPRBN/A

TNYAN/A

P/S Ratio

SPRB26.75x

TNYA94.33x

EV/Sales

SPRB8.59x

TNYA35.84x

EV/EBITDA

SPRB0.00x

TNYA0.00x

P/B Ratio

SPRB1.57x

TNYA1.82x

P/FCF Ratio

SPRBN/A

TNYAN/A

EV/FCF

SPRB-0.75x

TNYA-0.91x

PEG Ratio

SPRBN/A

TNYAN/A

Forward P/E (NTM)

SPRBN/A

TNYAN/A

Forward P/S (NTM)

SPRBN/A

TNYA20.11x

Revenue (TTM)

SPRB$0

TNYA$1M

Revenue Growth (YoY)

SPRBN/A

TNYAN/A

Forward Rev Growth

SPRB-75.6%

TNYA-49.9%

Gross Margin (TTM)

SPRB0.0%

TNYA0.0%

Operating Margin (TTM)

SPRB0.0%

TNYA0.0%

EBITDA Margin (TTM)

SPRB0.0%

TNYA-5657.2%

Net Margin (TTM)

SPRB0.0%

TNYA-7724.0%

FCF Margin (TTM)

SPRBN/A

TNYA-3939.2%

Net Income (TTM)

SPRB$-51M

TNYA$-103M

FCF (TTM)

SPRB$-43M

TNYA$-53M

EPS (TTM)

SPRB-$21.14

TNYA-$0.47

ROE (TTM)

SPRB-15540.0%

TNYA-10805.0%

ROA (TTM)

SPRB-10167.0%

TNYA-8584.0%

ROIC (TTM)

SPRB-14349.0%

TNYA-10805.0%

Cash

SPRB$96M

TNYA$78M

Debt

SPRB$7M

TNYA$0

Net Cash/Debt

SPRB$89M

TNYA$78M

Current Ratio (TTM)

SPRB9.23x

TNYA4.52x

Quick Ratio (TTM)

SPRB8.81x

TNYA4.34x

Debt/Equity (TTM)

SPRB0.08x

TNYA0.00x

Debt/Assets (TTM)

SPRB0.0%

TNYA0.0%

Interest Coverage (TTM)

SPRBN/A

TNYAN/A

Net Debt/EBITDA (TTM)

SPRB0.00x

TNYA0.00x

Beta

SPRB3.63

TNYA2.87

52W Performance

SPRB-72.5%

TNYA-68.3%

YTD Performance

SPRB-51.4%

TNYA-21.0%

% from 52W High

SPRB-77.9%

TNYA-75.3%

% from 52W Low

SPRB9.2%

TNYA11.4%

Asset Turnover (TTM)

SPRB0.07x

TNYA0.00x

FCF Yield (TTM)

SPRB-35.3%

TNYA-41.8%

Earnings Yield (TTM)

SPRB-42.4%

TNYA-81.9%

Dividend Yield (TTM)

SPRBN/A

TNYAN/A

Rule of 40

SPRB0.0

TNYA-3,939.2

EV/GP/RG

SPRBN/A

TNYAN/A

Ticker research

View SPRB research View TNYA research

Metric	SPRB Spruce Biosciences, Inc	TNYA Tenaya Therapeutics Inc
Market & Valuation
Market Cap	$121M	$126M
Enterprise Value	$32M	$48M
Price	$44.05	$0.58
P/E Ratio	N/A	N/A
P/S Ratio	26.75x	94.33x
EV/Sales	8.59x	35.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.57x	1.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.75x	-0.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	20.11x
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-75.6%	-49.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5657.2%
Net Margin (TTM)	0.0%	-7724.0%
FCF Margin (TTM)	N/A	-3939.2%
Net Income (TTM)	$-51M	$-103M
FCF (TTM)	$-43M	$-53M
EPS (TTM)	-$21.14	-$0.47
ROE (TTM)	-15540.0%	-10805.0%
ROA (TTM)	-10167.0%	-8584.0%
ROIC (TTM)	-14349.0%	-10805.0%
Financial Health
Cash	$96M	$78M
Debt	$7M	$0
Net Cash/Debt	$89M	$78M
Current Ratio (TTM)	9.23x	4.52x
Quick Ratio (TTM)	8.81x	4.34x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.63	2.87
52W Performance	-72.5%	-68.3%
YTD Performance	-51.4%	-21.0%
% from 52W High	-77.9%	-75.3%
% from 52W Low	9.2%	11.4%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.00x
FCF Yield (TTM)	-35.3%	-41.8%
Earnings Yield (TTM)	-42.4%	-81.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,939.2
EV/GP/RG	N/A	N/A
Ticker research	View SPRB research	View TNYA research

Valuation

P/S Ratio

SPRB

26.75x

TNYA

94.33x

EV/FCF

TNYA

-0.91x

SPRB

-0.75x

Growth & revenue

Forward Revenue Growth

TNYA

-49.9%

SPRB

-75.6%

Profitability & performance

Gross Margin

SPRB

0.0%

TNYA

0.0%

ROE

TNYA

-10805.0%

SPRB

-15540.0%

FCF Yield %

SPRB

-35.3%

TNYA

-41.8%

52-Week Performance

TNYA

-68.3%

SPRB

-72.5%

Detailed metrics comparison

SPRB

Spruce Biosciences, Inc

TNYA

Tenaya Therapeutics Inc

Market Cap

SPRB$121M

TNYA$126M

Enterprise Value

SPRB$32M

TNYA$48M

Price

SPRB$44.05

TNYA$0.58

P/E Ratio

SPRBN/A

TNYAN/A

P/S Ratio

SPRB26.75x

TNYA94.33x

EV/Sales

SPRB8.59x

TNYA35.84x

EV/EBITDA

SPRB0.00x

TNYA0.00x

P/B Ratio

SPRB1.57x

TNYA1.82x

P/FCF Ratio

SPRBN/A

TNYAN/A

EV/FCF

SPRB-0.75x

TNYA-0.91x

PEG Ratio

SPRBN/A

TNYAN/A

Forward P/E (NTM)

SPRBN/A

TNYAN/A

Forward P/S (NTM)

SPRBN/A

TNYA20.11x

Revenue (TTM)

SPRB$0

TNYA$1M

Revenue Growth (YoY)

SPRBN/A

TNYAN/A

Forward Rev Growth

SPRB-75.6%

TNYA-49.9%

Gross Margin (TTM)

SPRB0.0%

TNYA0.0%

Operating Margin (TTM)

SPRB0.0%

TNYA0.0%

EBITDA Margin (TTM)

SPRB0.0%

TNYA-5657.2%

Net Margin (TTM)

SPRB0.0%

TNYA-7724.0%

FCF Margin (TTM)

SPRBN/A

TNYA-3939.2%

Net Income (TTM)

SPRB$-51M

TNYA$-103M

FCF (TTM)

SPRB$-43M

TNYA$-53M

EPS (TTM)

SPRB-$21.14

TNYA-$0.47

ROE (TTM)

SPRB-15540.0%

TNYA-10805.0%

ROA (TTM)

SPRB-10167.0%

TNYA-8584.0%

ROIC (TTM)

SPRB-14349.0%

TNYA-10805.0%

Cash

SPRB$96M

TNYA$78M

Debt

SPRB$7M

TNYA$0

Net Cash/Debt

SPRB$89M

TNYA$78M

Current Ratio (TTM)

SPRB9.23x

TNYA4.52x

Quick Ratio (TTM)

SPRB8.81x

TNYA4.34x

Debt/Equity (TTM)

SPRB0.08x

TNYA0.00x

Debt/Assets (TTM)

SPRB0.0%

TNYA0.0%

Interest Coverage (TTM)

SPRBN/A

TNYAN/A

Net Debt/EBITDA (TTM)

SPRB0.00x

TNYA0.00x

Beta

SPRB3.63

TNYA2.87

52W Performance

SPRB-72.5%

TNYA-68.3%

YTD Performance

SPRB-51.4%

TNYA-21.0%

% from 52W High

SPRB-77.9%

TNYA-75.3%

% from 52W Low

SPRB9.2%

TNYA11.4%

Asset Turnover (TTM)

SPRB0.07x

TNYA0.00x

FCF Yield (TTM)

SPRB-35.3%

TNYA-41.8%

Earnings Yield (TTM)

SPRB-42.4%

TNYA-81.9%

Dividend Yield (TTM)

SPRBN/A

TNYAN/A

Rule of 40

SPRB0.0

TNYA-3,939.2

EV/GP/RG

SPRBN/A

TNYAN/A

Ticker research

View SPRB research View TNYA research

Metric	SPRB Spruce Biosciences, Inc	TNYA Tenaya Therapeutics Inc
Market & Valuation
Market Cap	$121M	$126M
Enterprise Value	$32M	$48M
Price	$44.05	$0.58
P/E Ratio	N/A	N/A
P/S Ratio	26.75x	94.33x
EV/Sales	8.59x	35.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.57x	1.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.75x	-0.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	20.11x
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-75.6%	-49.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5657.2%
Net Margin (TTM)	0.0%	-7724.0%
FCF Margin (TTM)	N/A	-3939.2%
Net Income (TTM)	$-51M	$-103M
FCF (TTM)	$-43M	$-53M
EPS (TTM)	-$21.14	-$0.47
ROE (TTM)	-15540.0%	-10805.0%
ROA (TTM)	-10167.0%	-8584.0%
ROIC (TTM)	-14349.0%	-10805.0%
Financial Health
Cash	$96M	$78M
Debt	$7M	$0
Net Cash/Debt	$89M	$78M
Current Ratio (TTM)	9.23x	4.52x
Quick Ratio (TTM)	8.81x	4.34x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.63	2.87
52W Performance	-72.5%	-68.3%
YTD Performance	-51.4%	-21.0%
% from 52W High	-77.9%	-75.3%
% from 52W Low	9.2%	11.4%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.00x
FCF Yield (TTM)	-35.3%	-41.8%
Earnings Yield (TTM)	-42.4%	-81.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,939.2
EV/GP/RG	N/A	N/A
Ticker research	View SPRB research	View TNYA research